Q1 Earnings Estimate for NTLA Issued By William Blair
Analysts at William Blair issued their Q1 2026 earnings estimates for shares of Intellia Therapeutics in a research report issued on Wednesday, March 26th. William Blair analyst M. Minter anticipates ...
What is William Blair’s Forecast for Neurogene Q1 Earnings?
Stock analysts at William Blair issued their Q1 2025 EPS estimates for Neurogene in a research report issued to clients and ...
Why the Army’s Vantage Decision Could Be a $619M Win for Palantir Stock (PLTR)
Shares of AI software company Palantir Technologies (PLTR) fell today, even after investment firm William Blair said that the ...
Army changes course, Palantir to stay prime contractor, says William Blair
William Blair analyst Louie DiPalma says the U.S. Army changed course and put the Army Data Platform 2.0 program on indefinite hold. In 2023, ...